We’re pleased to share our large-scale akathisia awareness ads are up and rolling on Utah buses. This campaign, our first in the mountain states, will run through August.
“MISSD believes publicizing akathisia-induced suicidality empowers healthcare consumers and providers to recognize the symptoms, facilitating early intervention and appropriate management strategies.”– Wendy Dolin, MISSD Founder
It’s good to see oncology recognize that olanzapine can induce akathisia in up to 16% of reported cases. As a result of akathisia, cancer patients “may experience significant distress.” Further, clinicians can easily miss or misdiagnose akathisia symptoms, leading to worse outcomes.
Read more at https://ascopubs.org/doi/full/10.1200/JCO.23.00853.
This excellent article by a well-known doctor and medical researcher explains how akathisia and tardive dyskinesia–two common and serious-prescription-drug-induced disorders are often overlooked, miscoded, and mistreated.
“The symptoms of akathisia may be overlooked because they resemble and often overlap with those of mania, psychosis, agitated depression, and the social construct called ADHD.”
Read more at https://www.madinamerica.com/2023/06/psychiatrys-denial-tardive-dyskinesia/.
BBC’s recent documentary is a must-see for anyone who wants to better understand the adverse effects of drugs marketed as antidepressants. The program features internal memos showing pharmaceutical companies hiding the risks before seeking drug regulator approval and misleading prescribers and consumers by downplaying serious withdrawal problems, including akathisia.
The media have long ignored this public health crisis. One sufferer interviewed by BBC stated, “I’ve been waiting 15 years for you (the media) to call.” Watch at https://www.youtube.com/watch?v=27aFEgjuYPw.
Nationally, it is estimated that since 2015, over 44% of Americans 12 and older have been prescribed one or more psychotropic drugs (including stimulants, antidepressants, anti-anxiety pills, mood stabilizers, and antipsychotics). The “Medicating Normal” Outreach Team is co-sponsoring an important petition—Protect Children: Reduce Over-Reliance on Psychoactive Drugs.
This petition calls for using already existing data from electronic health records (while maintaining the confidentiality of patients) to track and monitor a given region’s use of psychotropic medication(s). See and sign at https://www.change.org/p/protect-children-reduce-over-reliance-on-psychoactive-drugs?recruiter=709312496&recruited_by_id=f12e7c40-2290-11e7-9e0a-f902d8cecf86&utm_source=share_petition&utm_campaign=share_petition&utm_medium=copylink&utm_content=cl_sharecopy_36482231_en-US%3A8.
Tania and Ian Morgan, from Swansea, lost their 25-year-old son, Sam, when he killed himself in January 2020. They believe his death was caused by an adverse reaction to an antidepressant.
Other consumers were fortunate that the hospital crisis team recognized an “adverse reaction to the sertraline”(Zoloft) and took appropriate actions before it was too late.
“An adverse reaction to antidepressants can happen within hours,” says Professor Healy.
“In 2012 I was struggling with insomnia while going through a divorce and visited my doctor for sleeping pills. Instead, he prescribed the antidepressant escitalopram, which triggered a four-day delirium during which I hallucinated about how to end my life,” Katinka Newman, author of “The Pill that Steals Lives.”
Read the full article at https://www.dailymail.co.uk/health/article-12186777/Agony-families-say-pills-depression-led-children-lives.html.